These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1005 related items for PubMed ID: 26048746

  • 1. Stability Studies of a Freeze-Dried Recombinant Human Epidermal Growth Factor Formulation for Wound Healing.
    Santana H, García G, Vega M, Beldarraín A, Páez R.
    PDA J Pharm Sci Technol; 2015; 69(3):399-416. PubMed ID: 26048746
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist.
    Chang BS, Reeder G, Carpenter JF.
    Pharm Res; 1996 Feb; 13(2):243-9. PubMed ID: 8932444
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
    Passot S, Fonseca F, Alarcon-Lorca M, Rolland D, Marin M.
    Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
    [Abstract] [Full Text] [Related]

  • 9. Stabilization of a freeze-dried recombinant streptokinase formulation without serum albumin.
    López M, González LR, Reyes N, Sotolongo J, Pujol V.
    J Clin Pharm Ther; 2004 Aug; 29(4):367-73. PubMed ID: 15271104
    [Abstract] [Full Text] [Related]

  • 10. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.
    Abdul-Fattah AM, Lechuga-Ballesteros D, Kalonia DS, Pikal MJ.
    J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086
    [Abstract] [Full Text] [Related]

  • 11. Novel Mechanism of Glass Delamination in Type 1A Borosilicate Vials Containing Frozen Protein Formulations.
    Jiang G, Goss M, Li G, Jing W, Shen H, Fujimori K, Le L, Wong L, Wen ZQ, Nashed-Samuel Y, Riker K, Germansderfer A, Tsang P, Ricci M.
    PDA J Pharm Sci Technol; 2013 Jan; 67(4):323-35. PubMed ID: 23872443
    [Abstract] [Full Text] [Related]

  • 12. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
    Garidel P, Pevestorf B, Bahrenburg S.
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preparation of hydrogel embedded polymer-growth factor conjugated nanoparticles as a diabetic wound dressing.
    Hajimiri M, Shahverdi S, Esfandiari MA, Larijani B, Atyabi F, Rajabiani A, Dehpour AR, Amini M, Dinarvand R.
    Drug Dev Ind Pharm; 2016 Nov; 42(5):707-19. PubMed ID: 26289000
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of formulation variables on the stability of freeze-dried human growth hormone.
    Pikal MJ, Dellerman KM, Roy ML, Riggin RM.
    Pharm Res; 1991 Apr; 8(4):427-36. PubMed ID: 1871037
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.